EP1360207B1
(de)
*
|
2000-12-13 |
2011-06-22 |
Bac Ip B.V. |
Proteinraster aus variablen Domänen der schweren Immunoglobulinkette von Kamelen
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
EP2316487B1
(de)
|
2003-04-11 |
2014-06-11 |
MedImmune, LLC |
Rekombinante IL-9 Antikörper und ihre Verwendung
|
AU2004263896A1
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
WO2006059904A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Unilever N.V. |
Method for affinity purification
|
US7713695B2
(en)
|
2005-02-07 |
2010-05-11 |
Genenews, Inc. |
Mild osteoarthritis biomarkers and uses thereof
|
WO2006122787A1
(en)
|
2005-05-18 |
2006-11-23 |
Ablynx Nv |
Serum albumin binding proteins
|
KR101414438B1
(ko)
|
2005-05-20 |
2014-07-10 |
아블린쓰 엔.브이. |
폰 빌레브란트 인자에 대한 단일 도메인 vhh 항체
|
DE102005023617A1
(de)
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
US8249814B2
(en)
|
2005-10-21 |
2012-08-21 |
Genenews Inc. |
Method, computer readable medium, and system for determining a probability of colorectal cancer in a test subject
|
SG10201504662WA
(en)
|
2006-06-14 |
2015-07-30 |
Macrogenics Inc |
Methods For The Treatment Of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies With Reduced Toxicity
|
ES2439994T3
(es)
|
2006-08-28 |
2014-01-27 |
Kyowa Hakko Kirin Co., Ltd. |
Anticuerpos antagonistas monoclonales humanos específicos de LIGHT humano
|
EP3028716B1
(de)
|
2006-10-10 |
2020-09-16 |
Regenesance B.V. |
Komplementhemmung für verbesserte nervenregeneration
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
EP2557090A3
(de)
|
2006-12-19 |
2013-05-29 |
Ablynx N.V. |
Gegen GPCRs gerichtete Aminosäuresequenzen und Polypeptide damit zur Behandlung von Krankheiten und Störungen im Zusammenhang mit GPCR
|
WO2008118013A2
(en)
|
2007-03-23 |
2008-10-02 |
To-Bbb Holding B.V. |
Targeted intracellular delivery of antiviral agents
|
EP2068927B1
(de)
|
2007-05-14 |
2015-10-21 |
MedImmune, LLC |
Verfahren zur reduzierung eosinophiler spiegel
|
CA2691940C
(en)
|
2007-07-03 |
2018-03-06 |
Joost Alexander Kolkman |
Methods for providing improved immunoglobulin sequences
|
CA2694737C
(en)
|
2007-07-13 |
2019-05-14 |
Bac Ip B.V. |
Single-domain antigen-binding proteins that bind mammalian igg
|
BRPI0819656A2
(pt)
|
2007-11-27 |
2015-06-23 |
Ablynx Nv |
Seqüências de aminoácidos contras citocinas heterodiméricas e/ou seus receptores e polipeptídeos compreendendo as mesmas
|
EP2225275A4
(de)
|
2007-11-28 |
2013-04-03 |
Medimmune Llc |
Proteinformulierung
|
EP2247616A2
(de)
|
2008-03-05 |
2010-11-10 |
Ablynx N.V. |
Neuartige antigenbindende dimerkomplexe, verfahren zu ihrer herstellung und verwendungen davon
|
EP2260058A2
(de)
|
2008-04-07 |
2010-12-15 |
Ablynx N.V. |
Variable einzeldomänen gegen notch-signalwege
|
US8217140B2
(en)
|
2008-04-17 |
2012-07-10 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
EP2403873A1
(de)
|
2009-03-05 |
2012-01-11 |
Ablynx N.V. |
Neue antigenbindende dimerkomplexe, verfahren zur herstellung/vermeidung und anwendungen davon
|
EP2982690B1
(de)
|
2009-04-30 |
2021-01-27 |
Ablynx N.V. |
Verfahren zur herstellung von domänen-antikörpern
|
HUE051430T2
(hu)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Eljárás variábilis domének elõállítására
|
EP3438126B1
(de)
|
2009-09-03 |
2020-08-19 |
Ablynx N.V. |
Stabile formulierungen aus polypeptiden und verwendungen davon
|
PT2491056T
(pt)
*
|
2009-10-22 |
2021-10-26 |
Univ Of Twente |
Vhh para aplicação na reparação de tecidos, regeneração de órgãos, substituição de órgãos e engenharia de tecidos
|
WO2011083141A2
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Method for generation of immunoglobulin sequences by using lipoprotein particles
|
EP2531523A1
(de)
|
2010-02-05 |
2012-12-12 |
Ablynx N.V. |
An serumalbumin bindende peptide und verbindungen, konstrukte und polypeptide damit
|
PL2533761T3
(pl)
|
2010-02-11 |
2019-09-30 |
Ablynx N.V. |
Sposoby i kompozycje do wytwarzania aerozoli
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
CN102939004B
(zh)
|
2010-04-06 |
2015-09-23 |
阿格罗塞文公司 |
农用化学品的特异性输送
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
WO2012056000A1
(en)
|
2010-10-29 |
2012-05-03 |
Ablynx Nv |
Method for the production of immunoglobulin single variable domains
|
AR085091A1
(es)
|
2011-01-26 |
2013-09-11 |
Kolltan Pharmaceuticals Inc |
Anticuerpos anti-kit y sus usos
|
PT2691415T
(pt)
|
2011-03-28 |
2018-10-19 |
Ablynx Nv |
Método para produção de formulações sólidas compreendendo domínios variáveis únicos de imunoglobulina
|
EP2707382B1
(de)
|
2011-05-09 |
2019-07-17 |
Ablynx NV |
Verfahren zur herstellung von variablen immunglobulin-einzeldomänen
|
RU2661677C2
(ru)
|
2011-05-27 |
2018-07-18 |
Аблинкс Нв |
Ингибирование резорбции кости с помощью связывающих rank-l пептидов
|
CN104271598A
(zh)
|
2011-06-23 |
2015-01-07 |
埃博灵克斯股份有限公司 |
针对IgE的免疫球蛋白单可变结构域
|
EP3311837A1
(de)
|
2011-09-23 |
2018-04-25 |
Ablynx NV |
Verlängerte hemmung der interleukin-6-vermittelten signalisierung
|
CA2851040A1
(en)
|
2011-10-06 |
2013-04-11 |
Agrosavfe N.V. |
Manufacturing of specifically targeting microcapsules
|
JP6411333B2
(ja)
|
2012-05-24 |
2018-10-24 |
ブイアイビー ブイゼットダブリュVib Vzw |
腫瘍関連マクロファージのターゲティングおよびinvivoイメージング用抗マクロファージマンノース受容体単一可変ドメイン
|
EP4063391A1
(de)
|
2012-07-25 |
2022-09-28 |
Celldex Therapeutics, Inc. |
Anti-kit-antikörper und verwendungen davon
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
JP6443344B2
(ja)
|
2013-01-30 |
2018-12-26 |
フエー・イー・ベー・フエー・ゼツト・ウエー |
スクリーニングおよび薬物開発のための新規キメラポリペプチド
|
PT2953973T
(pt)
|
2013-02-05 |
2019-10-25 |
Univ Brussel Vrije |
Agentes de ligação do receptor muscarínico de acetilololina e usos
|
CA2906259C
(en)
|
2013-03-15 |
2022-12-06 |
Vib Vzw |
Anti-mmr single variable domains for prognosis and monitoring of cardiovascular diseases
|
PL2992101T3
(pl)
|
2013-04-29 |
2019-05-31 |
Agrosavfe Nv |
Kompozycje agrochemiczne zawierające przeciwciała wiążące się ze sfingolipidami
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
SG10201708143QA
(en)
|
2013-06-06 |
2017-11-29 |
Pierre Fabre Médicament |
Anti-c10orf54 antibodies and uses thereof
|
EP2883883A1
(de)
|
2013-12-16 |
2015-06-17 |
Cardio3 Biosciences S.A. |
Therapeutische Ziele und Mittel zur Behandlung von ischämiebedingten Reperfusionsschäden
|
AU2015217846B2
(en)
|
2014-01-30 |
2019-10-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Opioid receptor binding agents and uses thereof
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
CN108064242B
(zh)
|
2014-05-28 |
2022-10-21 |
阿吉纳斯公司 |
抗gitr抗体和其使用方法
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
DK3194976T3
(da)
|
2014-07-22 |
2020-07-13 |
Vib Vzw |
Fremgangsmåder til udvælgelse af midler, som stabiliserer proteinkomplekser
|
EP3718574A1
(de)
|
2014-07-29 |
2020-10-07 |
Vrije Universiteit Brussel |
Radioaktiv markierte antikörperfragmente zur verwendung bei der vorbeugung und/oder behandlung von krebs
|
US20180036442A1
(en)
|
2014-07-29 |
2018-02-08 |
Vrije Universiteit Brussel |
Radio-labelled antibody fragments for use in the prognosis, diagnosis of cancer as well as for the prediction of cancer therapy response
|
EP3215624B1
(de)
|
2014-11-05 |
2023-11-29 |
Biotalys NV |
Transgene pflanzen mit einem für die variable domäne eines schwerkettigen antikörpers codierendem polynukleotid
|
WO2016097313A1
(en)
|
2014-12-19 |
2016-06-23 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
WO2016106221A1
(en)
|
2014-12-22 |
2016-06-30 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
SG11201705310TA
(en)
|
2014-12-30 |
2017-07-28 |
Celgene Corp |
Anti-cd47 antibodies and uses thereof
|
FI3265123T3
(fi)
|
2015-03-03 |
2023-01-31 |
|
Vasta-aineita, käyttöjä & menetelmiä
|
SG11201707538XA
(en)
|
2015-03-17 |
2017-10-30 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
MY189692A
(en)
|
2015-05-07 |
2022-02-26 |
Memorial Sloan Kettering Cancer Center |
Anti-ox40 antibodies and methods of use thereof
|
PT3303394T
(pt)
|
2015-05-29 |
2020-07-01 |
Ludwig Inst For Cancer Res Ltd |
Anticorpos anti-ctla-4 e métodos de uso dos mesmos
|
JP6917357B2
(ja)
|
2015-07-17 |
2021-08-11 |
フレイエ ユニヴェルシテイト ブリュッセルVrije Universiteit Brussel |
癌治療に使用する放射標識抗体断片
|
KR20220131277A
(ko)
|
2015-09-01 |
2022-09-27 |
아게누스 인코포레이티드 |
항-pd-1 항체 및 이를 이용하는 방법
|
SG11201803976VA
(en)
|
2015-11-27 |
2018-06-28 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
US11243214B2
(en)
|
2016-04-22 |
2022-02-08 |
Université Libre de Bruxelles |
Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
WO2017182605A1
(en)
|
2016-04-22 |
2017-10-26 |
Université Libre de Bruxelles |
A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
|
CN109311968A
(zh)
|
2016-05-02 |
2019-02-05 |
埃博灵克斯股份有限公司 |
治疗rsv感染
|
MA45123A
(fr)
|
2016-05-27 |
2019-04-10 |
Agenus Inc |
Anticorps anti-tim-3 et leurs méthodes d'utilisation
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
AU2017292184A1
(en)
|
2016-07-08 |
2019-02-07 |
Staten Biotechnology B.V. |
Anti-Apoc3 antibodies and methods of use thereof
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
US11098113B2
(en)
|
2016-09-15 |
2021-08-24 |
Vib Vzw |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
CN110023337B
(zh)
|
2016-10-11 |
2024-01-05 |
艾吉纳斯公司 |
抗lag-3抗体及其使用方法
|
US11779604B2
(en)
|
2016-11-03 |
2023-10-10 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses and methods
|
US11332521B2
(en)
|
2016-11-07 |
2022-05-17 |
Neuracle Science Co., Ltd. |
Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof
|
WO2018091606A1
(en)
|
2016-11-16 |
2018-05-24 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
CA3046082A1
(en)
|
2016-12-07 |
2018-06-14 |
Agenus Inc. |
Antibodies and methods of use thereof
|
AU2017373944B2
(en)
|
2016-12-07 |
2022-02-03 |
Agenus Inc. |
Anti-CTLA-4 antibodies and methods of use thereof
|
EP3589725A1
(de)
|
2017-02-28 |
2020-01-08 |
Vib Vzw |
Mittel und verfahren zur oralen proteinabgabe
|
US20200064341A1
(en)
*
|
2017-03-14 |
2020-02-27 |
Nanotag Biotechnologies Gmbh |
Target detection using a monovalent antibody
|
MX2019011624A
(es)
|
2017-03-27 |
2019-12-05 |
Celgene Corp |
Metodos y composiciones para la reduccion de la inmunogenicidad.
|
BR112019017241A2
(pt)
|
2017-04-13 |
2020-04-14 |
Agenus Inc |
anticorpos anti-cd137 e métodos de uso dos mesmos
|
CA3058290A1
(en)
|
2017-04-18 |
2018-10-25 |
Universite Libre De Bruxelles |
Biomarkers and targets for proliferative diseases
|
JP2020517242A
(ja)
|
2017-04-21 |
2020-06-18 |
スターテン・バイオテクノロジー・ベー・フェー |
抗ApoC3抗体およびその使用方法
|
EP3618863B1
(de)
|
2017-05-01 |
2023-07-26 |
Agenus Inc. |
Anti-tigit antikörper und deren verwendung
|
KR20200005635A
(ko)
|
2017-05-11 |
2020-01-15 |
브이아이비 브이지더블유 |
가변 면역글로불린 도메인의 글리코실화
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
KR20200013247A
(ko)
|
2017-06-02 |
2020-02-06 |
아블린쓰 엔.브이. |
아그레칸 결합 면역글로불린
|
EP3630847A1
(de)
|
2017-06-02 |
2020-04-08 |
Merck Patent GmbH |
Adamts-bindende immunoglobuline
|
BR112019025097A2
(pt)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
imunoglobulinas de ligação a mmp13
|
JP7249961B2
(ja)
|
2017-06-02 |
2023-03-31 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Adamts5、mmp13およびアグリカンに結合するポリペプチド
|
US11613588B2
(en)
|
2017-06-28 |
2023-03-28 |
The Rockefeller University |
Anti-mertk agonistic antibodies and uses thereof
|
WO2019016237A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
AGENTS FOR CONNECTING TO SERUM ALBUMIN
|
EP3470436A1
(de)
*
|
2017-10-11 |
2019-04-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Anti-igg-nanokörper
|
WO2019086548A1
(en)
|
2017-10-31 |
2019-05-09 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
CN111315772A
(zh)
|
2017-10-31 |
2020-06-19 |
斯塔顿生物技术有限公司 |
抗apoc3抗体及其使用方法
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
CA3092421A1
(en)
|
2018-03-01 |
2019-09-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
EP4163295A1
(de)
|
2018-03-23 |
2023-04-12 |
Université Libre de Bruxelles |
Agonistenmoleküle des wnt-signalwegs
|
MX2020010091A
(es)
|
2018-03-27 |
2021-01-15 |
Umc Utrecht Holding Bv |
Trombolisis direccionada para tratamiento de trombosis microvascular.
|
KR20240056644A
(ko)
|
2018-05-10 |
2024-04-30 |
주식회사 뉴라클사이언스 |
서열 유사성 19, 멤버 a5 항체를 갖는 항-패밀리 및 그의 사용 방법
|
JP7298607B2
(ja)
*
|
2018-06-20 |
2023-06-27 |
Jsr株式会社 |
変異vhh抗体を用いたアフィニティー担体
|
MX2020013923A
(es)
|
2018-06-29 |
2021-03-29 |
Apitbio Inc |
Anticuerpos anti molécula de adhesión celular l1 (l1cam) y usos de estos.
|
CN112740043A
(zh)
|
2018-07-20 |
2021-04-30 |
皮埃尔法布雷医药公司 |
Vista受体
|
KR20210070300A
(ko)
|
2018-10-03 |
2021-06-14 |
스태튼 바이오테크놀로지 비.브이. |
사람 및 시노몰구스 ApoC3에 대해 특이적인 항체 및 이의 사용 방법
|
EP4378958A2
(de)
|
2019-02-26 |
2024-06-05 |
Inspirna, Inc. |
Anti-mertk-antikörper mit hoher affinität und ihre verwendung
|
CA3138028A1
(en)
|
2019-04-29 |
2020-11-05 |
Confo Therapeutics N.V. |
Chimeric proteins and methods to screen for compounds and ligands binding to gpcrs
|
US20220289837A1
(en)
|
2019-04-30 |
2022-09-15 |
Vib Vzw |
Cystic Fibrosis Transmembrane Conductance Regulator Stabilizing Agents
|
EP3976650A1
(de)
|
2019-05-28 |
2022-04-06 |
Vib Vzw |
Krebsbehandlung durch abzielen auf plexine im immunbereich
|
US20220228116A1
(en)
|
2019-05-28 |
2022-07-21 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
WO2021042019A1
(en)
|
2019-08-30 |
2021-03-04 |
Agenus Inc. |
Anti-cd96 antibodies and methods of use thereof
|
US20220380456A1
(en)
|
2019-10-21 |
2022-12-01 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
CA3160506A1
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
EP4065603A1
(de)
|
2019-11-27 |
2022-10-05 |
Vib Vzw |
Positive allosterische modulatoren des calciumempfindlichen rezeptors
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
EP4077372A1
(de)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanokörperaustauschchromatographie
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
WO2021170540A1
(en)
|
2020-02-25 |
2021-09-02 |
Vib Vzw |
Leucine-rich repeat kinase 2 allosteric modulators
|
US20230110053A1
(en)
|
2020-03-31 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
EP4144758A4
(de)
|
2020-04-22 |
2024-05-15 |
Mabwell Shanghai Bioscience Co Ltd |
Gegen den humanen liganden 1 für programmierten zelltod (pd-l1) gerichteter einzelvariabler domänenantikörper und derivat davon
|
WO2021221050A1
(ja)
|
2020-04-27 |
2021-11-04 |
株式会社カネカ |
構造物及びその製造方法、それを用いた吸着体、並びに生体粒子の精製方法
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
AU2021319024A1
(en)
|
2020-07-31 |
2023-03-23 |
Biotalys NV |
Expression host
|
US20230364049A1
(en)
|
2020-09-24 |
2023-11-16 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
US20220153854A1
(en)
|
2020-09-25 |
2022-05-19 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
JP2024508207A
(ja)
|
2020-12-02 |
2024-02-26 |
ブイアイビー ブイゼットダブリュ |
がんに対する組み合わせ治療におけるltbrアゴニスト
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
TW202239763A
(zh)
|
2020-12-18 |
2022-10-16 |
比利時商艾伯霖克斯公司 |
包含靶向IL-6和TNF-α的免疫球蛋白單可變結構域的多肽
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
CA3206124A1
(en)
|
2020-12-24 |
2022-06-30 |
Vib Vzw |
Non-blocking human ccr8 binders
|
WO2022136647A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Human ccr8 binders
|
EP4267621A1
(de)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Kreuzreaktive menschliche ccr8-bindemittel aus der maus
|
EP4288095A1
(de)
|
2021-02-05 |
2023-12-13 |
Vib Vzw |
Sarbecovirus-bindemittel
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
CA3211257A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
EP4294516A1
(de)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Kationunabhängige mannose-6-phosphatrezeptorbindemittel
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
EP4314068A1
(de)
|
2021-04-02 |
2024-02-07 |
The Regents Of The University Of California |
Antikörper gegen gespaltenes cdcp1 und verwendungen davon
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
CN117580865A
(zh)
|
2021-06-29 |
2024-02-20 |
山东先声生物制药有限公司 |
Cd16抗体及其应用
|
AU2022320667A1
(en)
|
2021-07-30 |
2024-03-14 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibody and application
|
WO2023016828A2
(en)
|
2021-07-30 |
2023-02-16 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
WO2023057601A1
(en)
|
2021-10-06 |
2023-04-13 |
Biotalys NV |
Anti-fungal polypeptides
|
TW202342508A
(zh)
|
2021-12-17 |
2023-11-01 |
比利時商艾伯霖克斯公司 |
包含靶向TCRαβ、CD33和CD123的免疫球蛋白單可變結構域的多肽
|
WO2023135198A1
(en)
|
2022-01-12 |
2023-07-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
WO2023148291A1
(en)
|
2022-02-02 |
2023-08-10 |
Biotalys NV |
Methods for genome editing
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
WO2023198848A1
(en)
|
2022-04-13 |
2023-10-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
WO2023213751A1
(en)
|
2022-05-02 |
2023-11-09 |
Umc Utrecht Holding B.V |
Single domain antibodies for the detection of plasmin-cleaved vwf
|
WO2023222825A1
(en)
|
2022-05-18 |
2023-11-23 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
WO2023240124A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Pseudotyped viral particles for targeting tcr-expressing cells
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
WO2024105091A1
(en)
|
2022-11-15 |
2024-05-23 |
Imec Vzw |
Method and system for droplet manipulation
|